Danaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.
- Revenue
- +8.28%
- EPS
- +36.7%
- Free cash flow
- +19.1%
- Total debt
- +44.9%
Quarter to September 2026, against a year earlier
Follow DHR
Alert me
Danaher Corporation (DHR) EV/FCF
As of 5 November 2026, Danaher Corporation (DHR) trades at a EV/FCF of 30.9×. Over the past ten years it has ranged from 11.4× (September 2015) to 43.4× (August 2024); the current reading is higher than 74% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 33.4× | (2.06%) |
| FY2024 | 34.1× | 7.61% |
| FY2023 | 31.7× | 29.89% |
| FY2022 | 24.4× | (23.32%) |
| FY2021 | 31.9× | 12.34% |
| FY2020 | 28.4× | (4.16%) |
| FY2019 | 29.6× | 40.19% |
| FY2018 | 21.1× | (6.69%) |
| FY2017 | 22.6× | 17.17% |
| FY2016 | 19.3× | 17.93% |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 30.4× | 7.43% |
| Jun 2026 | 28.3× | 2.90% |
| Mar 2026 | 27.5× | (17.84%) |
| Dec 2025 | 33.4× | 7.61% |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| IQV IQVIA Holdings Inc. compare | 27.5× |
| DHR Danaher Corporation | 30.9× |
| ILMN Illumina, Inc. compare | 31.3× |
| TMO Thermo Fisher Scientific Inc. compare | 37.2× |
| A Agilent Technologies, Inc. compare | 39.7× |
| IDXX IDEXX Laboratories, Inc. compare | 40.7× |
| MTD Mettler-Toledo International, Inc. compare | 41.4× |
| WAT Waters Corporation compare | 190× |
| NTRA Natera, Inc. compare | 991× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on DHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement